Evidence map›Paper›PMID 32554468›Full record

ArticleThe Journal of biological chemistry2020

Discordance between GLP-1R gene and protein expression in mouse pancreatic islet cells.

Sarah M Gray, Yurong Xin, Elizabeth C Ross, Bryanna M Chazotte, Megan E Capozzi, Kimberley El, Berit Svendsen, Peter Ravn, Kyle W Sloop, Jenny Tong and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Liraglutide increases islet CaDiabetes, obesity & metabolism · 2022
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Sarah M GrayDuke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.ORCID 0000-0003-2370-7968
Yurong XinRegeneron Pharmaceuticals, Tarrytown, New York, USA.
Elizabeth C RossDuke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.
Bryanna M ChazotteDuke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.
Megan E CapozziDuke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.
Kimberley ElDuke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.ORCID 0000-0002-5550-1684
Berit SvendsenDuke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.ORCID 0000-0002-3604-000X
Peter RavnAntibody Discovery and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
Kyle W SloopDiabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA.
Jenny TongDepartment of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, Washington, USA.
Jesper GromadaRegeneron Pharmaceuticals, Tarrytown, New York, USA.
Jonathan E CampbellDuke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.ORCID 0000-0003-4358-6331
David A D'AlessioDuke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA david.d'alessio@duke.edu.
Duke University · USRegeneron (United States) · USAstraZeneca (United Kingdom) · GBEli Lilly (United States) · USUniversity of Washington · US

Funding

Endocrinology and Metabolism Training ProgramT32DK007012 · NIDDK · DUKE UNIVERSITY · PI DAVID A. D'ALESSIO · 1986 to 2026
$6.8M
Mechanisms of insulin secretion mediated by alpha cellsR01DK123075 · NIDDK · DUKE UNIVERSITY · PI CAMPBELL, JONATHAN E · 2019 to 2023
$1.9M
Incretin Action in Physiology and DiabetesR01DK101991 · NIDDK · DUKE UNIVERSITY · PI D'ALESSIO, DAVID A. · 2014 to 2018
$1.8M
The Role of Islet DPP4 for Regulation of Glucose HomeostasisF32DK116542 · NIDDK · DUKE UNIVERSITY · PI CAPOZZI, MEGAN · 2018 to 2020
$188k
Nutrient-dependent action of glucagon and GLP-1 in glucose metabolism and insulin secretionF32DK121420 · NIDDK · DUKE UNIVERSITY · PI GRAY, SARAH MARIE · 2019 to 2020
$85k
NIDDK NIH HHS F32 DK116542NIDDK NIH HHS F32 DK121420NIDDK NIH HHS R01 DK101991NIDDK NIH HHS R01 DK123075NIDDK NIH HHS T32 DK007012
6 · The paper itself

Abstract

The insulinotropic actions of glucagon-like peptide 1 receptor (GLP-1R) in β-cells have made it a useful target to manage type 2 diabetes. Metabolic stress reduces β-cell sensitivity to GLP-1, yet the underlying mechanisms are unknown. We hypothesized that

Indexed as

AnimalsCells, CulturedGene ExpressionGlucagon-Like Peptide-1 ReceptorHumansInsulin-Secreting CellsMiceMice, Inbred C57BLSingle-Cell AnalysisGlucagon-Like Peptide-1 Receptorcell sortingflow cytometryGLP-1R antibodyglucagon-like peptide 1 receptor (GLP-1R)glucose-dependent insulinotropic polypeptide receptor (GIPR)G protein–coupled receptor (GPCR)heterogeneityincretinisletmetabolism

Identifiers

PMID32554468
PMCPMC7450118
OpenAlexW3036314870

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.